“A Huge Relief”: Stand Up for Science Celebrates Stopping Controversial Hep-B Vaccine Study in Guinea-Bissau
EIN Presswire
WASHINGTON, DC, UNITED STATES, October 21, 2026 /EINPresswire.com/ -- Following the news that the controversial Hepatitis B vaccine safety study in Guinea-Bissau newborns has been canceled permanently, Stand Up for Science is celebrating the...
As CDC Renews Controversial Guinea-Bissau Vaccine Trial, Stand Up for Science Makes Its Field Investigation Public
EIN Presswire
March 2026 report previously shared only in Congressional briefings documents ethics, consent, and conflict-of-interest concerns WASHINGTON, DC, UNITED STATES, October 15, 2026 /EINPresswire.com/ -- Amid reports that CDC intends to fund a...
Stand Up for Science Condemns CDC’s Attempts to Restart Controversial Vaccine Study in Guinea-Bissau
EIN Presswire
WASHINGTON, DC, UNITED STATES, October 8, 2026 /EINPresswire.com/ -- Following reports that the CDC intends to move forward with a previously-canceled study of the Hepatitis B vaccine in newborns in Guinea-Bissau, Stand Up for Science Founder...
Guinea-Bissau Stops Trump-Backed Hepatitis B Vaccine Study
MENAFN
(MENAFN) Guinea-Bissau has terminated a contentious hepatitis B vaccine trial bankrolled by the Trump administration following a sharp ethical rebuke from the World Health Organization (WHO), which warned the study risked causing irreversible harm...
Guinea-Bissau Stops US-Funded Hepatitis B Vaccine Trial
MENAFN
(MENAFN) Guinea-Bissau has terminated a controversial hepatitis B vaccine study financed by the administration of US President Donald Trump after the World Health Organization raised ethical concerns about the project’s design.
STAND UP FOR SCIENCE: CDC-FUNDED HEPATITIS B STUDY IN GUINEA-BISSAU CANCELLED
EIN Presswire
On-the-ground investigation raised alarms about safeguards for children, conflicts of interest, and grant oversight.
FII Institute and FTI Consulting launch the Preventive Health Readiness Index
Video Stories
Sign up for:
Guinea Bissau Health Bulletin
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.